SeekingAlpha · Dec 11, 2025
DMB: Growing Tax Free Income While Preserving Capital
BNY Mellon Municipal Bond Infrastructure Fund, Inc. is rated a Buy for its higher yield and wider discount. Learn more about DMB CEF here.
NA
NYSE · NAD
Nuveen Quality Municipal Income Fund
Financial Services · Asset Management - Income
$10.94
Down-$0.21 (-1.88%)
Updated Sep 11, 2026, 3:05 AM
SID Score
3.6/10
Composite research score
Smart Money
54/100
Neutral
- Market cap
- 2.83B
- P/E ratio
- 49.41
- Dividend yield
- 8.84%
- 52-week range
- $11.11 – $12.31
- Volume
- 1.89M
- Avg. volume
- 698.15K
Price performance
NAD price history
1M range · 20 trading sessions · Daily adjusted prices
NAD closed at $10.94 after 20 trading sessions, down 7.83% for the selected period.
- Last close
- $10.94
- Period change
- -7.83%
- Period low
- $10.94
- Period high
- $11.87
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 10, 2026 | $11.11 | $11.115 | $10.89 | $10.94 | 1.89M |
| Sep 9, 2026 | $11.30 | $11.34 | $11.11 | $11.15 | 1.33M |
| Sep 8, 2026 | $11.41 | $11.44 | $11.34 | $11.34 | 793.38K |
| Sep 4, 2026 | $11.46 | $11.49 | $11.41 | $11.46 | 644.74K |
| Sep 3, 2026 | $11.45 | $11.48 | $11.40 | $11.46 | 1.05M |
| Sep 2, 2026 | $11.55 | $11.57 | $11.41 | $11.41 | 756.16K |
| Sep 1, 2026 | $11.71 | $11.71 | $11.55 | $11.56 | 1.06M |
| Aug 31, 2026 | $11.67 | $11.74 | $11.65 | $11.74 | 708.01K |
| Aug 28, 2026 | $11.75 | $11.76 | $11.69 | $11.70 | 513.12K |
| Aug 27, 2026 | $11.67 | $11.75 | $11.67 | $11.75 | 548.4K |
| Aug 26, 2026 | $11.72 | $11.72 | $11.68 | $11.70 | 390.91K |
| Aug 25, 2026 | $11.72 | $11.72 | $11.665 | $11.69 | 605.7K |
| Aug 24, 2026 | $11.70 | $11.9031 | $11.64 | $11.65 | 416.33K |
| Aug 21, 2026 | $11.66 | $11.67 | $11.64 | $11.67 | 511.51K |
| Aug 20, 2026 | $11.74 | $11.78 | $11.66 | $11.66 | 584.27K |
| Aug 19, 2026 | $11.77 | $11.81 | $11.75 | $11.81 | 565.37K |
| Aug 18, 2026 | $11.73 | $11.735 | $11.68 | $11.70 | 561.95K |
| Aug 17, 2026 | $11.85 | $11.85 | $11.72 | $11.75 | 622.67K |
| Aug 14, 2026 | $11.80 | $11.87 | $11.74 | $11.87 | 690.01K |
| Aug 13, 2026 | $11.82 | $11.87 | $11.79 | $11.87 | 547.75K |
Latest NAD news
The latest Smart Investors Daily articles mentioning NAD.
Stock researchCompany · Overview
NAD research
Overview
Company profile and research snapshot.
Company profile
Nuveen Quality Municipal Income Fund is a diversified, closed-end management investment company. Its investment objective is to provide current income exempted from regular federal income tax by investing in tax-exempt municipal securities that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
SeekingAlpha · Nov 27, 2025
XMPT: Discounted Muni CEF Exposure Providing Significant Diversification
Read here for more on VanEck CEF Municipal Income ETF's (XMPT) high-yield muni bond exposure, CEF discount insights, and diversification benefits.
SeekingAlpha · Nov 21, 2025
RFMZ: Best Value Of The Lineup
RiverNorth Flexible Municipal Income II offers unique trading value among muni CEFs. Here's what investors need to know about RFMZ.
businesswire.com · Nov 13, 2025
Niagen Bioscience Launches Tru Niagen® Beauty — The First NAD+ Skincare Supplement in the U.S. Featuring Niagen® (Patented Nicotinamide Riboside)
LOS ANGELES--(BUSINESS WIRE)---- $NAGE #Biotech--Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced the launch of Tru Niagen® Beauty, the first-ever beauty supplement in the US featuring Niagen (patented nicotinamide riboside or NR) — the most efficient, effective, and high quality NAD+ booster available. Tru Niagen Beauty expands Niagen Bioscience's leadership in NAD+ skincare science with a cellul.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
